Women with ovarian cancer will benefit from a new research centre aimed at improving diagnosis and treatment of the disease.
The Nicola Murray Centre for Ovarian Cancer Research will seek to advance understanding of the different types of the disease so that patients can be offered the most effective treatment for their specific condition.
The unit is being established with generous support from the family and friends of Ms Murray, who died from the condition in 2010 at the age of 34.
Scientists will investigate the biological differences between types of ovarian cancer and how they affect patients’ response to treatments.
Some forms of ovarian cancer – such as the one Ms Murray had – are particularly aggressive and hard to treat.
The team will focus on understanding how these types of tumours grow and why some forms of the disease respond better than others to medication.
Researchers hope this will help develop new treatments that can tackle even the most resistant forms.
Ms Murray, a speech and language therapist from Dunfermline, died less than four months after her diagnosis.
She had a rare and aggressive form of the disease – known as HNPCC-associated ovarian cancer – which is caused by a fault in one of the genes that normally suppresses tumour growth.
The Nicola Murray Foundation - which has raised over £200,000 - was set up in her memory as a means to perpetuate the care and concern that she showed to others in her life.
We are extremely grateful to Nicola’s family and friends for supporting our research so enthusiastically. We believe that this centre will help us develop new strategies to target the specific abnormalities in each patient’s cancer and improve the outcome for patients with this terrible disease.
Caroline Turnbull, Nicola’s sister and co-founder of the Nicola Murray Foundation, said that when Nicola learned that the treatment pathways for her ovarian cancer were under-researched, she began planning fundraising activities for her family and friends.
Nicola was determined that no other young women should go through what happened to her. She knew that new research into treatments would bring hope and light to other young women on their ovarian cancer journey.